Lupin is set to acquire five legacy pharmaceutical brands, including Piclin, Menoctyl, Sucramal O, Pyridium, and Distaclor, in the fields of gastroenterology, urology, and anti-infectives from Menarini, along with trademark rights. The deal, valued at approximately Rs 100 crore, was announced through a BSE filing, with no further financial details disclosed.
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/OC45jw8
Subscribe to:
Post Comments (Atom)
Report: 93% Indian executives see rise in cyber budget next year
from Business News: Business News, Business News Today, Latest Business News, Stock Markets, Financial News, India Business & World Bu...
-
A woman, in her early 20s, was stabbed to death by a man in southeast Delhi's Bhogal area on Friday evening, following which the accused...
-
Collecting Lego — yes, the plastic toys made of interlocking bricks that become cars and castles and robots —returned more than large stocks...
-
The Delhi High Court on Thursday dismissed the pleas of TTV Dhinakaran and VK Sasikala challenging the Election Commission's order grant...
No comments:
Post a Comment